Thromboembolic Risk of Subcutaneous Immunoglobulin and Hormonal Contraceptives in Common Variable Immunodeficiency: A Case Report and Literature Review
A 32-year-old female patient diagnosed with common variable immunodeficiency and pelvic endometriosis faced a complex clinical dilemma regarding the overlapping thromboembolic risks of subcutaneous immunoglobulin replacement therapy and combined estrogen-progesterone … Read More